V.J. Woeckel

1α,25‐(OH)₂D₃ acts in the early phase of osteoblast differentiation to enhance mineralization via accelerated production of mature matrix vesicles

V.J. Woeckel, Rodrigo D. A. M. Alves, Sigrid Swagemakers et al. · Journal of Cellular Physiology · 2010 · 80 citations · Full text

1α,25‐dihydroxyvitamin D₃ stimulates activin A production to fine‐tune osteoblast‐induced mineralization

V.J. Woeckel, Bram C. J. van der Eerden, Marijke Schreuders‐Koedam et al. · Journal of Cellular Physiology · 2013 · 34 citations · Full text

Activin Activity, Bone Health, Health Sciences +15

IFNβ impairs extracellular matrix formation leading to inhibition of mineralization by effects in the early stage of human osteoblast differentiation

V.J. Woeckel, Marco Eijken, Jeroen van de Peppel et al. · Journal of Cellular Physiology · 2011 · 32 citations · Full text

Immunology, Immune Regulation, Bone Repair +24

Evidence of vitamin D and interferon‐β cross‐talk in human osteoblasts with 1α,25‐dihydroxyvitamin D₃ being dominant over interferon‐β in stimulating mineralization

V.J. Woeckel, Marijke Koedam, Jeroen van de Peppel et al. · Journal of Cellular Physiology · 2011 · 23 citations · Full text

Osteogenesis, Osteoporosis, Transcriptional Regulation +17

1α,25-Dihydroxyvitamin D3 and rosiglitazone synergistically enhance osteoblast-mediated mineralization

V.J. Woeckel, Claudia Bruedigam, Marijke Koedam et al. · Gene · 2012 · 16 citations

Medicine, 1α,25-Dihydroxyvitamin D3, Pharmacology +3